Drugs & aging
-
To evaluate the 104-week safety of dapagliflozin in older patients with type 2 diabetes mellitus. ⋯ Dapagliflozin treatment up to 104 weeks was well tolerated in older patients. Older dapagliflozin-treated patients had more renal AEs than placebo-treated patients; the majority of which were non-serious small transient changes in serum creatinine.